Coagulants and Anti-Coagulants
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
DABIGATRAN ETEXILATE: products 1 to 6 of 6.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Dabigatran 110mg CapDIN 02468905 | General benefit | $1.2540per source unit | Requirements & sourcesBuild cost plan |
| Apo-Dabigatran 150mg CapDIN 02468913 | General benefit | $1.2540per source unit | Requirements & sourcesBuild cost plan |
| Apo-Dabigatran 75mg CapDIN 02468891 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Pradaxa 110mg CapDIN 02312441 | General benefit | $1.2540per source unit | Requirements & sourcesBuild cost plan |
| Pradaxa 150mg CapDIN 02358808 | General benefit | $1.2540per source unit | Requirements & sourcesBuild cost plan |
| Pradaxa 75mg CapDIN 02312433 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
20:12 Coagulants and Anti-Coagulants.
20:12:04 Direct Factor Xa Inhibitors.
20:12:16 Hemostatics.